ЕВОЛЮЦІЯ МЕДИЧНОЇ ПАРАДИГМИ: ВИКЛИКИ ТА ПЕРСПЕКТИВИ У ВНУТРІШНІЙ МЕДИЦИНІ DOI Open Access

Ірина Лоскутова,

Самі Абуватфа,

A.S. Shapovalova

et al.

Перспективи та інновації науки, Journal Year: 2023, Volume and Issue: 16(34)

Published: Dec. 29, 2023

ЕВОЛЮЦІЯ МЕДИЧНОЇ ПАРАДИГМИ: ВИКЛИКИ ТА ПЕРСПЕКТИВИ У ВНУТРІШНІЙ МЕДИЦИНІАнотація.Авторами статті досліджена динаміка розвитку внутрішньої медицини в контексті сучасних трансформацій медичної науки та практики.Проведений аналіз ключових викликів, які стоять перед сучасною медициною, спрогнозовані ймовірні перспективи.Особлива увага приділяється науковим інноваціям, технологічним досягненням персоналізованим підходам до діагностики й лікування на основі аналізу досліджень вітчизняних зарубіжних науковців власного досвіду.Розглядається вплив технологій, зміни структурі захворювань глобальні виклики сучасну медичну практику.Стаття спрямована визначення шляхів оптимізації вдосконалення у світлі нових можливостей

Application of a meshed artificial dermal scaffold and negative-pressure wound therapy in the treatment of full-thickness skin defects: a prospective in vivo study DOI Creative Commons
Pei Wei, Lijiao Wu, Hongteng Xie

et al.

Biomaterials Science, Journal Year: 2024, Volume and Issue: 12(7), P. 1914 - 1923

Published: Jan. 1, 2024

A novel meshed ADS combined with NPWT can reduce the risk of scaffold-related complications, which helps to improve quality wound repair and promotes a broader range applications.

Language: Английский

Citations

2

Cancer research revolutionized: Unveiling the power of organoids and their therapeutic potential in oncology DOI Creative Commons

Yingxin Zhang,

Ming Liu,

Xie Na

et al.

hLife, Journal Year: 2024, Volume and Issue: unknown

Published: May 1, 2024

Organoids are in vitro microstructures similar to the source tissue formed by self-organizing construction of stem cells from various sources. It is now widely recognized as a powerful model facilitate cancer research and personalized precision therapy. Since successful establishment first organoid 2009, there has been global upsurge research. At present, organoids have used on mechanism occurrence development, study cell interactions tumor microenvironment, development screening new drugs, individualized treatment cancer. In addition, chip technology biobanks expected further promote irreplaceable role medical treatment. this review, we offer comprehensive outline historical their advantages, focusing latest progress application We also discuss problems that need be solved potential applications organoids. This review summarizes impact treatment, provide view

Language: Английский

Citations

2

Emergent trends in organ-on-a-chip applications for investigating metastasis within tumor microenvironment: A comprehensive bibliometric analysis DOI Creative Commons

Chunrong He,

Fangfang Lu,

Yi Liu

et al.

Heliyon, Journal Year: 2023, Volume and Issue: 10(1), P. e23504 - e23504

Published: Dec. 9, 2023

With the burgeoning advancements in disease modeling, drug development, and precision medicine, organ-on-a-chip has risen to forefront of biomedical research. Specifically tumor research, this technology exhibited exceptional potential elucidating dynamics metastasis within microenvironment. Recognizing significance field, our study aims provide a comprehensive bibliometric analysis global scientific contributions related organ-on-a-chip.

Language: Английский

Citations

4

iPSC-derived cells for whole liver bioengineering DOI Creative Commons
Kayque A. Telles-Silva, Lara Pacheco,

Fernanda Chianca

et al.

Frontiers in Bioengineering and Biotechnology, Journal Year: 2024, Volume and Issue: 12

Published: Feb. 7, 2024

Liver bioengineering stands as a prominent alternative to conventional hepatic transplantation. Through liver decellularization and/or bioprinting, researchers can generate acellular scaffolds overcome immune rejection, genetic manipulation, and ethical concerns that often accompany traditional transplantation methods, in vivo regeneration, xenotransplantation. Hepatic cell lines derived from induced pluripotent stem cells (iPSCs) repopulate decellularized bioprinted scaffolds, producing an increasingly functional organ potentially suitable for autologous use. In this mini-review, we overview recent advancements vitro hepatocyte differentiation protocols, shedding light on their pivotal role recellularization thereby offering novel source Finally, identify future directions research may allow the implementation of these systems diverse applications, including drug screening disease modeling.

Language: Английский

Citations

1

Bioprinting of aptamer-based programmable bioinks to modulate multiscale microvascular morphogenesis in 4D DOI Creative Commons
Deepti Rana, Vincent R. Rangel, Prasanna Padmanaban

et al.

bioRxiv (Cold Spring Harbor Laboratory), Journal Year: 2024, Volume and Issue: unknown

Published: June 17, 2024

Abstract Dynamic growth factor presentation influences how individual endothelial cells assemble into complex vascular networks. Here, we developed programmable bioinks that facilitate dynamic VEGF to guide morphogenesis within 3D-bioprinted constructs. We leveraged aptamer’s high affinity for rapid sequestration in spatially confined regions and utilized aptamer-complementary sequence (CS) hybridization tune release kinetics temporally, days after bioprinting. show spatial resolution of bioink, combined with CS-triggered release, significantly alignment, organization, microvascular networks bioprinted The presence aptamer-tethered the generation instantaneous gradients upon CS-triggering restricted hierarchical network formation printed aptamer at all resolutions. Network properties improved as decreased, low-resolution designs yielding highest properties. Specifically, CS-treated exhibited significant remodeling, increase vessel density(1.35-fold), branching density(1.54-fold), average length(2.19-fold) compared non-treated samples. Our results suggests CS acts an external trigger capable inducing time-controlled changes organization alignment on-demand localized a construct. envision these will open new opportunities bioengineering functional, hierarchically self-organized engineered tissues.

Language: Английский

Citations

1

In Vitro Cell Line Culture for Brain Research and Its Limitations DOI

Shalakha V. Dabhekar,

Mrunali D. Dhokne,

V. Dalal

et al.

Published: Jan. 1, 2024

Language: Английский

Citations

1

Advances in the Construction and Application of Bone‐on‐a‐Chip Based on Microfluidic Technologies DOI

Chang Zhong,

Zihui Tang,

Xin Yu

et al.

Journal of Biomedical Materials Research Part B Applied Biomaterials, Journal Year: 2024, Volume and Issue: 112(12)

Published: Nov. 18, 2024

ABSTRACT Bone‐on‐a‐chip (BOC) models that based on microfluidic technology have widely applied to understand bone physiology and the pathogenesis of related diseases. In this review, we provide an overview biology diseases, explain advantages applications in construction BOC models, summarize their progress physiology, pathology, drug development. Finally, discussed problems be solved future directions platforms, so as a reference for researchers design better models.

Language: Английский

Citations

1

Effective and new technologies in kidney tissue engineering DOI Creative Commons
Hossein Rayat Pisheh, Mobin Haghdel, Muhammad Jahangir

et al.

Frontiers in Bioengineering and Biotechnology, Journal Year: 2024, Volume and Issue: 12

Published: Oct. 16, 2024

Kidney disease encompasses a wide spectrum of conditions, ranging from simple infections to chronic kidney disease. When the kidneys are unable filter blood and remove waste products, these abnormalities can lead failure. In severe cases failure, transplantation is considered only definitive treatment. Worldwide, World Health Organization (WHO) repeatedly emphasizes importance organ donation increasing rates. Many countries implement national programs promote culture improve patient access transplantation. The extent which this procedure performed varies across influenced by several factors, including volume donation, medical infrastructure, technology health policies. However, transplant comes with challenges problems that impact its success. tissue engineering new approach shows promise for repairing replacing damaged tissue. This article reviews recent advances in engineering, focusing on engineered structures such as hydrogels, electrospinning, 3D bioprinting, microfluidic systems. By mimicking extracellular environment kidney, provide suitable conditions growth development cells. role formation vessels, mimicry functions field were also discussed. results study show has high potential treating diseases reducing need achieve clinical application technology, further research required biocompatibility, vascularization long-term performance tissues.

Language: Английский

Citations

1

Bioprinting of Aptamer‐Based Programmable Bioinks to Modulate Multiscale Microvascular Morphogenesis in 4D DOI Creative Commons
Deepti Rana, Vincent R. Rangel, Prasanna Padmanaban

et al.

Advanced Healthcare Materials, Journal Year: 2024, Volume and Issue: unknown

Published: Nov. 1, 2024

Dynamic growth factor presentation influences how individual endothelial cells assemble into complex vascular networks. Here, programmable bioinks are developed that facilitate dynamic (VEGF) to guide morphogenesis within 3D-bioprinted constructs. Aptamer's high affinity is leveraged for rapid VEGF sequestration in spatially confined regions and utilized aptamer-complementary sequence (CS) hybridization tune release kinetics temporally, days after bioprinting. It shown spatial resolution of bioink, combined with CS-triggered release, significantly the alignment, organization, microvascular networks bioprinted The presence aptamer-tethered generation instantaneous gradients upon CS-triggering restricted hierarchical network formation printed aptamer at all resolutions. Network properties improved as decreased, low-resolution designs yielding highest properties. Specifically, CS-treated exhibited significant remodeling, an increase vessel density(1.35-fold), branching density(1.54-fold), average length(2.19-fold) compared non-treated samples. results suggest CS acts external trigger capable inducing time-controlled changes organization alignment on-demand localized a construct. envisioned these will open new opportunities bioengineering functional, hierarchically self-organized engineered tissues.

Language: Английский

Citations

1

Engineering blood and lymphatic microvascular networks DOI

Aldina Crnic,

Sabrina Rohringer,

Tatiana Tyschuk

et al.

Atherosclerosis, Journal Year: 2024, Volume and Issue: 393, P. 117458 - 117458

Published: Jan. 23, 2024

Language: Английский

Citations

0